Published in Wiad Lek on March 15, 1968
Neural differentiation of pluripotent mouse embryonal carcinoma cells by retinoic acid: inhibitory effect of serum. Physiol Res (2005) 0.99
The influence of wine polyphenols on reactive oxygen and nitrogen species production by murine macrophages RAW 264.7. Physiol Res (2007) 0.97
Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production. Free Radic Res (2012) 0.84
Carvedilol and adrenergic agonists suppress the lipopolysaccharide-induced NO production in RAW 264.7 macrophages via the adrenergic receptors. J Physiol Pharmacol (2009) 0.83
Leukocyte mobilization, chemiluminescence response, and antioxidative capacity of the blood in intestinal ischemia and reperfusion. Free Radic Res (1997) 0.82
Comparative investigations of the influence of H1-antihistamines on the generation of reactive oxygen species by phagocytes. Inflamm Res (2008) 0.82
Total antioxidant capacity of serum increased in early but not late period after intestinal ischemia in rats. Free Radic Biol Med (1998) 0.82
Ischemia/reperfusion injury of rat small intestine: the effect of allopurinol dosage. Transplant Proc (2001) 0.81
Neural differentiation potentiated by the leukaemia inhibitory factor through STAT3 signalling in mouse embryonal carcinoma cells. Folia Biol (Praha) (2007) 0.81
The effect of intestinal ischemia duration on changes in plasma antioxidant defense status in rats. Physiol Res (2004) 0.81
Blood phagocyte activation during open heart surgery with cardiopulmonary bypass. Physiol Res (2005) 0.80
New luminescence-based approach to measurement of luciferase gene expression reporter activity and adenosine triphosphate-based determination of cell viability. Folia Biol (Praha) (2010) 0.79
IL-10 does not affect oxidative burst and expression of selected surface antigen on human blood phagocytes in vitro. Physiol Res (2004) 0.77
The expression of NADPH oxidases and production of reactive oxygen species by human lung adenocarcinoma epithelial cell line A549. Folia Biol (Praha) (2010) 0.76
Silkworm (Bombyx mori) hemocytes do not produce reactive oxygen metabolites as a part of defense mechanisms. Folia Microbiol (Praha) (2004) 0.76
[Case of oidiomycosis with unusual course]. Wiad Lek (1971) 0.75
[Osmotic diabetic coma]. Pol Tyg Lek (1967) 0.75
[Studies on anemia in pregnancy]. Z Gesamte Inn Med (1966) 0.75
[Progress in renal physiopathology]. Pol Arch Med Wewn (1966) 0.75
Differential effects of v-Jun and c-Jun proteins on v-myb-transformed monoblasts. Cell Mol Life Sci (2002) 0.75
[Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis]. Pol Merkur Lekarski (1997) 0.75
[Antioxidative action of pyridoindoles and N-(alkoxyphenyl)-2-(2-oxo-1-aza-1-cycloalkyl) acetamides in biological, enzymatic and chemical systems]. Ceska Slov Farm (2003) 0.75
Phagocyte-derived oxidants and plasma antioxidants in haemodialysed patients. Scand J Clin Lab Invest (2007) 0.75
[Advances in physiopathology]. Pol Arch Med Wewn (1967) 0.75
[Combined treatment with hydrazinophthalazines and beta sympatholytic agents of nephrogenic hypertension]. Pol Tyg Lek (1976) 0.75
Phagocyte-induced oxidative stress in patients with haemodialysis treatment and organ transplantation. Biofactors (1998) 0.75
[Progress in physiopathology]. Pol Arch Med Wewn (1966) 0.75
[20 episodes of acute non-inflammatory renal failure in acquired hemolytic anemia]. Pol Arch Med Wewn (1982) 0.75
[Arteriovenous fistulas for hemodialysis in patients with chronic renal failure]. Pol Przegl Chir (1977) 0.75
[Combined immunosuppressive treatment of systemic lupus erythematosus]. Pol Arch Med Wewn (1974) 0.75
[Anemias of pregnancy]. Pol Arch Med Wewn (1966) 0.75
[Immunosuppression in Sjogren's syndrome with a pseudo-leukemic lymphocyte reaction]. Pol Tyg Lek (1970) 0.75
Short and prolonged survival in Hodgkin's disease. Pol Med J (1968) 0.75
Prerenal uremia in chronic renal diseases. 3. Diagnosis. Pol Med J (1969) 0.75
[Case of ascites during treatment with repeated dialysis]. Pol Arch Med Wewn (1978) 0.75
Prerenal uremia in chronic renal diseases. II. Prerenal uremia due to hypovolemia. Pol Med J (1969) 0.75
[Results of 2-year use of the immunosuppressive drugs dipyridamole and methindol in the treatment of patients with chronic mesangiocapillary glomerulonephritis]. Pol Tyg Lek (1987) 0.75
Prerenal uremia in chronic renal diseases. I. Prerenal uremia due to circulatory failure. Pol Med J (1969) 0.75
[Usefulness of the Cytur-Test in clinical practice]. Pol Tyg Lek (1986) 0.75
[Sorbonit in the treatment of coronary disease]. Wiad Lek (1968) 0.75
[Long and short survival in Hodgkin's disease]. Pol Arch Med Wewn (1967) 0.75